Main Menu

Target Validation and DNA Damage Response Team

Prof. Tutt’s team interests involve the discovery of novel therapies and biomarkers in BRCA1/BRCA2-associated cancers and ER/HER2-negative/basal-like breast cancers – including the identification of new drug targets and therapy combination strategies.

Team Members

Dr Nick Balan

Higher Scientific Officer

Dr Kathryn Davidson

Higher Scientific Officer

Dr Callum Walker

Postdoctoral Fellow

Dr Daniel Weekes

Postdoctoral Fellow
We use cookies to ensure that we give you the best experience on our website. By continuing to use this website, you are agreeing to our use of cookies on your device as described in our cookie policy. You can change your cookie settings at any time but parts of our site will not function correctly without them.